Launch Coincides with Mental Health Awareness Month to Amplify Focus on Mental Well-being
NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) — Counslr, a leading digital mental health company, and Sack the Stigma, a mental health advocacy organization dedicated to reducing the stigma surrounding mental health challenges within student athletics, announced a strategic partnership to expand curated resources for Counslr’s Wellness Toolkit. Specifically, the partnership will integrate Sack the Stigma’s Mental Health Playbook’s Campaign into Counslr’s platform, to empower users to proactively manage and prioritize their mental health through easy-to-use and engaging materials.
“At Counslr, our mission has always been to make mental health support as accessible, approachable, and effective as possible,” said Josh Liss, co-founder and CEO of Counslr. “By featuring Sack the Stigma’s Mental Health Playbook’s Campaign in our Wellness Toolkit, we’re providing even more tools for individuals to navigate life’s challenges in a positive and empowering way.”
Sack the Stigma’s Mental Health Playbook’s Campaign features collegiate athletes sharing practical strategies and personal stories covering a range of mental wellness topics, including stress management, coping skills and self-care techniques.
“Partnering with Counslr enables us to extend the impact of the Mental Health Playbook’s Campaign to more individuals who can benefit from practical, stigma-free mental health resources,” said Brett Gray, Sack the Stigma Director of Business Affairs and Operations. “Together, we are normalizing mental health care and by providing do-it-yourself resources and thereby making it easier for people to prioritize their mental well-being every day.”
The partnership reflects a shared commitment to removing barriers to mental health support, building resilience, and fostering healthier communities through education, advocacy, and innovation.
For more information on Counslr, please visit: www.counslr.com.
For more information on Sack the Stigma, please visit: www.sackthestigma.com.
ABOUT COUNSLR
Counslr is a text-based mental health support application that provides unlimited access to robust wellness resources and live texting sessions with licensed professionals, 24/7/365. Users can access support on-demand within two minutes of opening the app, or by scheduled appointment. Through real-time texting, users enjoy one-on-one, private communication with a licensed counselor that can be conducted anytime, anywhere. Counslr was designed to help individuals deal with life’s day-to-day issues, empowering individuals to address concerns while they are “small” to help ensure that they stay “small”. Counslr partners with organizations of all shapes and sizes (companies, unions, nonprofits, universities/colleges, high schools, etc) so that these entities can provide Counslr’s services to their employees/members/students at no direct cost. For more information, please visit www.counslr.com.
ABOUT SACK THE STIGMA
Sack the Stigma was created in 2021 with the intention of destigmatizing mental health struggles (for everyone) and increasing access to mental healthcare among the current and former student-athlete population. Our goals are threefold: raise awareness of this issue, educate students on available (feasible) resources, and ultimately increase access to mental healthcare opportunities among this subset of university students. Through the sale of thoughtfully designed merchandise collections and execution of interactive events, we raise money and drive awareness of university-wide mental health resources, thereby ensuring athletes are properly cared for and supported (and awareness for the whole population is reached).
For media inquiries, please contact Kristen Nihamin at 917-509-9028 or kristen@counslr.com
– Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI)…
D-bal-max D-Bal MAX Glasgow, June 15, 2025 (GLOBE NEWSWIRE) -- In the quest for enhanced…
Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment…
Results from the Phase 2 RedirecTT-1 study demonstrate deep responses with 78.9 percent overall response…
After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients…
77% of patients (150 mg Q4W) treated with barzolvolimab who had angioedema at baseline were…